Skip to main content
. 2017 Jul 10;6:e26801. doi: 10.7554/eLife.26801

Table 1.

The means and SEM for each experiment for PD patients and HC on all measures taken. Within each experiment, one-way ANOVAs were run between PD patients and HC (χ2 for the genders), and paired t-tests for the comparisons between patients ON and OFF medication for the UPDRS. MMSE scores from experiment 1 were converted to MoCA scores for comparison. *p<0.05, **p<0.01, ***p<0.001.

DOI: http://dx.doi.org/10.7554/eLife.26801.021

Experiment 1 2 3
Measure PD patients HC PD patients HC PD patients HC
Number 18 18 18 20 18 18
Gender (M/F) 15/3** 7/11 16/2*** 5/15 11/7 11/7
Age 71.56 (2.06) 71.19 (2.52) 67.39 (2.10) 66.05 (2.05) 69.11 (1.44) 71.61 (2.05)
Years Education 13.50 (0.66) 12.93 (0.89) 14.83 (0.91) 13.75 (0.56) 11.94 (0.52)* 14.72 (0.65)
MoCA 29.44 (0.12) 29.63 (0.13) 28.72 (0.50)* 26.85 (0.53) 27.61 (0.54) 26.78 (0.56)
DASS 21.71 (2.85)* 12.19 (2.76) 15.39 (2.54) 20.05 (5.50) 29.13 (4.53)** 10.44 (2.29)
 Depression 6.35 (0.81)** 2.88 (0.87) 4.94 (1.13) 5.55 (1.958) 7.13 (1.71)*** 2.78 (0.75)
 Anxiety 7.88 (1.27)** 3.25 (0.88) 5.67 (0.84) 5.50 (1.80) 10.33 (1.58)*** 2.61 (0.69)
 Stress 7.47 (1.41) 6.06 (1.32) 4.78 (1.09) 9.00 (2.02) 11.67 (1.73)** 5.06 (1.25)
BIS 14.94 (2.36) 15.31 (3.07) 53.50 (2.47) 51.90 (2.35) 53.56 (2.70) 51.00 (1.88)
LARS −20.22 (1.36)*** −27.44 (1.24) −23.50 (1.71)* −30.00 (1.58) −22.44 (2.06)* −27.06 (1.16)
UPDRS ON 18.67 (2.69) 18.78 (2.85) 26.50 (2.73)
UPDRS OFF 24.56 (3.41)*** 23.28 (2.97) 30.44 (2.52)***
Years since diagnosis 4.44 (1.21) 4.39 (0.90) 5.00 (1.02)
Years since symptoms 5.18 (1.28) 4.78 (0.86) 6.44 (1.10)
LDE (mg) 566.41 (61.18) 543.70 (67.36) 653.00 (93.96)
# levodopa/ dopamine agonists/both 12/1/5 10/2/6 10/0/8
# on XL meds 3 10 9

MoCA=Montreal Cognitive Assessment, DASS=Depression, Anxiety and Stress Scale, BIS=Barratt Impulsivity Scale, LARS=Lille Apathy Rating Scale, UPDRS=Unified Parkinson’s Disease Rating Scale, LDE=Levodopa Dose Equivalence.